Ifosfamide with regional hyperthermia in soft-tissue sarcomas

Oncology

Volumn 65, Issue SUPPL. 2, 2003, Pages 76-79

  Schlemmer, M ^a   Wendtner, C M ^a   Issels, R D ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Ifosfamide; Neoadjuvant chemotherapy; Regional hyperthermia; Soft tissue sarcoma

Indexed keywords

DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE;

CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; HIGH RISK PATIENT; HIGH TEMPERATURE; HUMAN; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; TREATMENT OUTCOME; TREATMENT PLANNING;

ANTINEOPLASTIC AGENTS, ALKYLATING; CHEMOTHERAPY, ADJUVANT; HUMANS; HYPERTHERMIA, INDUCED; IFOSFAMIDE; NEOADJUVANT THERAPY; SARCOMA;

EID: 0242288528     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073365     Document Type: Conference Paper

References (23)

1. Enzinger FM, Weiss SW: Soft Tissue Tumors. St Louis, Mosby, 1988.
2. Pisters PWT, Harrison LB, Leung DHY et al: Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996;14:859-868.
3. Yang JC, Chang AE, Baker AR et al: Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998;16:197-203.
4. Alvarenga JC, Ball ABS, Fisher C et al: Limitations of surgery in the treatment of sarcoma. Br J Surg 1991;78:912-916.
5. Fein DA, Lee WR, Lanciano RM et al: Management of extremity soft tissue sarcomas with limb-sparing surgery and postoperative irradiation: Do total dose, overall treatment time and the surgery-radiotherapy interval impact on local control? Int J Radiat Oncol Biol Phys 1995;32:969-976.
6. Gaynor JJ, Tan CC, Casper ES et al: Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: A study of 423 adults. J Clin Oncol 1992;10:1317-1327.
7. Bautista N, Su W, O'Connell TX: Retroperitoneal soft-tissue sarcomas: Prognosis and treatment of primary and recurrent disease. Am Surg 2000;66:832-836.
8. Makela J, Kiviniemi H, Laitinen S: Prognostic factors predicting survival in the treatment of retroperitoneal sarcoma. Eur J Surg Oncol 2000;26:552-555.
9. Falk M, Issels RD: Hyperthermia in oncology. Int J Hyperthermia 2000;17:1-16.
10. Nielsen OS, Horsman M, Overgaard J: A future for hyperthermia in cancer treatment? Eur J Cancer 2001;37:1587-1589.
11. Dewey WC: Interaction of heat with radiation and chemotherapy. Cancer Res 1984;44:4714-4720.
12. Hyperthermia and the immune systeme (special issue). Int J Hyperthermia 2002;18:486-608.
13. Prosnitz LR, Maguire P, Anderson JM et al: The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy. Int J Radiat Oncol Biol Phys 1999;45:941-949.
14. Gortzak E, Azzarelli A, Buesa J et al: A randomised phase II study on neoadjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma. Eur J Cancer 2001;37:1096-1103.
15. Pezzi CM, Pollock RE, Evans HL et al: Preoperative chemotherapy for soft-tissue sarcomas of the extremities. Ann Surg 1999;211:476-481.
16. Rouesse JG, Friedman S, Sevin DM et al: Preoperative induction chemotherapy in the treatment of locally advanced soft tissue sarcomas. Cancer 1987;60:296-300.
17. Pisters PWT, Patel SR, Varma DGK et al: Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: Long-term results form a single institution. J Clin Oncol 1997;15:3481-3487.
18. Issels RD, Prenninger SW, Nagele A et al: Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: A phase II study. J Clin Oncol 1990;8:1818-1829.
19. Issels RD, Mittermüller J, Gerl A et al: Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: Updated report on 65 patients. J Cancer Res Clin Oncol 1991;117(suppl 4):141-147.
20. Issels RD, Abdel-Rahman S, Wendtner CM et al: Neoadjuvant chemotherapy combined with regional hyperthermia for locally advanced primary or recurrent high-risk soft tissue sarcomas of adults: Long-term results of a phase II study. Eur J Cancer 2001;37:1599-1608.
21. Wendtner CM, Abdel-Rahman S, Baumert J et al: Treatment of primary, recurrent or inadequately resected high-risk soft tissue sarcomas of adults: Results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia. Eur J Cancer 2001;37:1609-1616.
22. Wendtner CM, Abdel-Rahman S, Krych M et al: Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas. J Clin Oncol 2000;20:3156-3164.
23. EORTC 62961/ESHO RHT-95: Randomized study comparing neoadjuvant chemotherapy etoposide + ifosfamide + adriamycin (EIA) combined with regional hyperthermia versus neoadjuvant chemotherapy alone in the treatment of high-risk soft tissue sarcomas in adults. http://www.med.uni-muenchen.de/tzm/ eortc